INmune Bio, Inc.
NASDAQ:INMBBiotechnology
Healthcare
$1.89 +8.38%
+$0.15 today
- Market cap
- $50.25M
- Beta
- 0.98
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$1.56
52W Low $1.09High $3.24
Volume 0.09M
Average 0.68M
Private 5-step workspace
Build a INMB investment thesis
Turn INmune Bio, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.